CN103074359B - 使用细胞内同步表达法在t4噬菌体表面展示外源蛋白大分子的方法 - Google Patents
使用细胞内同步表达法在t4噬菌体表面展示外源蛋白大分子的方法 Download PDFInfo
- Publication number
- CN103074359B CN103074359B CN201310033512.3A CN201310033512A CN103074359B CN 103074359 B CN103074359 B CN 103074359B CN 201310033512 A CN201310033512 A CN 201310033512A CN 103074359 B CN103074359 B CN 103074359B
- Authority
- CN
- China
- Prior art keywords
- protein
- recombinant protein
- albumen
- phage
- plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 130
- 238000000034 method Methods 0.000 title claims abstract description 76
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 62
- 230000014509 gene expression Effects 0.000 title claims abstract description 20
- 241001515965 unidentified phage Species 0.000 title abstract 7
- 229920002521 macromolecule Polymers 0.000 title abstract 3
- 230000003834 intracellular effect Effects 0.000 title abstract 2
- 230000001360 synchronised effect Effects 0.000 title abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims abstract description 108
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims abstract description 108
- 239000002245 particle Substances 0.000 claims abstract description 37
- 241000588724 Escherichia coli Species 0.000 claims abstract description 26
- 239000013613 expression plasmid Substances 0.000 claims abstract description 21
- 210000000234 capsid Anatomy 0.000 claims abstract description 19
- 208000015181 infectious disease Diseases 0.000 claims abstract description 10
- 239000013612 plasmid Substances 0.000 claims description 43
- 230000010076 replication Effects 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 230000003321 amplification Effects 0.000 claims description 23
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 23
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 230000012743 protein tagging Effects 0.000 claims description 20
- 239000013600 plasmid vector Substances 0.000 claims description 16
- 239000006228 supernatant Substances 0.000 claims description 15
- 238000011144 upstream manufacturing Methods 0.000 claims description 15
- 108020004414 DNA Proteins 0.000 claims description 14
- 238000013461 design Methods 0.000 claims description 12
- 238000002823 phage display Methods 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 10
- 108091026890 Coding region Proteins 0.000 claims description 9
- 238000013016 damping Methods 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 241000700605 Viruses Species 0.000 claims description 7
- 239000003242 anti bacterial agent Substances 0.000 claims description 7
- 238000001085 differential centrifugation Methods 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- 102000012410 DNA Ligases Human genes 0.000 claims description 5
- 108010061982 DNA Ligases Proteins 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 5
- 238000010561 standard procedure Methods 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 238000002306 biochemical method Methods 0.000 claims description 3
- 230000001276 controlling effect Effects 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 230000008021 deposition Effects 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 230000029087 digestion Effects 0.000 claims description 3
- 230000007774 longterm Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 239000013049 sediment Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 238000000746 purification Methods 0.000 abstract description 9
- 238000000926 separation method Methods 0.000 abstract description 7
- 230000002018 overexpression Effects 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 18
- 238000012360 testing method Methods 0.000 description 7
- 108020005038 Terminator Codon Proteins 0.000 description 6
- 108091006027 G proteins Proteins 0.000 description 5
- 102000030782 GTP binding Human genes 0.000 description 5
- 108091000058 GTP-Binding Proteins 0.000 description 5
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000003946 protein process Effects 0.000 description 1
- 229960002203 tilactase Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310033512.3A CN103074359B (zh) | 2013-01-29 | 2013-01-29 | 使用细胞内同步表达法在t4噬菌体表面展示外源蛋白大分子的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310033512.3A CN103074359B (zh) | 2013-01-29 | 2013-01-29 | 使用细胞内同步表达法在t4噬菌体表面展示外源蛋白大分子的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103074359A CN103074359A (zh) | 2013-05-01 |
CN103074359B true CN103074359B (zh) | 2014-10-29 |
Family
ID=48151054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310033512.3A Active CN103074359B (zh) | 2013-01-29 | 2013-01-29 | 使用细胞内同步表达法在t4噬菌体表面展示外源蛋白大分子的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103074359B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111954683A (zh) * | 2018-04-05 | 2020-11-17 | 生物辐射Abd瑟罗泰克有限公司 | 感兴趣的蛋白质的展示系统 |
CN110878320A (zh) * | 2018-09-05 | 2020-03-13 | 湖北微生元生物科技有限公司 | 使用t4噬菌体展示技术高效表达超敏蛋白的方法 |
CN110885847A (zh) * | 2018-09-05 | 2020-03-17 | 湖北微生元生物科技有限公司 | 使用t4噬菌体展示技术高效表达超敏蛋白的方法 |
CN109652432A (zh) * | 2018-12-25 | 2019-04-19 | 华中科技大学鄂州工业技术研究院 | 一种高纯度隐地蛋白的制备方法 |
CN109666686A (zh) * | 2018-12-25 | 2019-04-23 | 华中科技大学鄂州工业技术研究院 | 一种高纯度隐地蛋白的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1602962A (zh) * | 2004-08-04 | 2005-04-06 | 任兆钧 | 口蹄疫全病毒基因工程疫苗及其制备方法 |
US20060068379A1 (en) * | 1997-04-11 | 2006-03-30 | Steven Alasdair C | Phage display of intact domains at high copy number |
CN1972710A (zh) * | 2003-12-17 | 2007-05-30 | 美国天主教大学 | 包含噬菌体纳米颗粒的方法和组合物 |
-
2013
- 2013-01-29 CN CN201310033512.3A patent/CN103074359B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060068379A1 (en) * | 1997-04-11 | 2006-03-30 | Steven Alasdair C | Phage display of intact domains at high copy number |
CN1972710A (zh) * | 2003-12-17 | 2007-05-30 | 美国天主教大学 | 包含噬菌体纳米颗粒的方法和组合物 |
CN1602962A (zh) * | 2004-08-04 | 2005-04-06 | 任兆钧 | 口蹄疫全病毒基因工程疫苗及其制备方法 |
Non-Patent Citations (2)
Title |
---|
噬菌体展示技术系统发展进展;孟繁梅 等;《遗传》;20111031;第33卷(第10期);第3.3.2节 * |
孟繁梅 等.噬菌体展示技术系统发展进展.《遗传》.2011,第33卷(第10期),1113-1120. |
Also Published As
Publication number | Publication date |
---|---|
CN103074359A (zh) | 2013-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103074359B (zh) | 使用细胞内同步表达法在t4噬菌体表面展示外源蛋白大分子的方法 | |
CN104004095B (zh) | 一种cd7纳米抗体、其编码序列及应用 | |
CN108753792B (zh) | 绿色荧光蛋白纳米抗体的编码基因及其制备方法和应用 | |
Berndt et al. | Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii | |
CN104725515A (zh) | 一种类弹性蛋白多肽与柯萨奇腺病毒受体融合蛋白及其制备方法和应用 | |
CN105255895B (zh) | 用于真核细胞系的提高蛋白表达水平的mar转录调控元件及其表达系统 | |
Branston et al. | Investigation of the impact of Tat export pathway enhancement on E. coli culture, protein production and early stage recovery | |
Srivastava et al. | Expressing full-length functional PfEMP1 proteins in the HEK293 expression system | |
CN114773487A (zh) | 一种流感病毒和新型冠状病毒融合重组蛋白疫苗免疫原及其制备方法 | |
CN106191090A (zh) | 无抗生素表达外源基因的蓝藻工程菌系统及其制备和应用 | |
Loomis et al. | InsectDirect TM System: rapid, high-level protein expression and purification from insect cells | |
Mayrhofer et al. | Functional trimeric SARS-CoV-2 envelope protein expressed in stable CHO cells | |
Zhang et al. | Construction of an expression vector that uses the aph promoter for protein expression in Corynebacterium glutamicum | |
CN107653266A (zh) | 含鳞翅目病毒增强子的重组表达载体在双翅目昆虫细胞中表达蛋白的应用 | |
CN115850507B (zh) | 一种正交、双组份蛋白质自组装偶联体系及其构建方法 | |
US20120009624A1 (en) | Protein particles | |
Snead et al. | Polycistronic baculovirus expression of SUGT1 enables high-yield production of recombinant leucine-rich repeat proteins and protein complexes | |
CN104762285A (zh) | 一种自内裂解大肠杆菌的裂解酶及其应用 | |
CN113061611B (zh) | 果蝇myc纳米抗体的编码基因及制备方法和应用 | |
Song et al. | Effect of SpyTag/SpyCatcher cyclization on stability and refolding of green fluorescent protein | |
CN105296478B (zh) | 一种多标签抗原及其制备方法和应用 | |
Pierce et al. | A comparison of the process issues in expressing the same recombinant enzyme periplasmically in Escherichia coli and extracellularly in Streptomyces lividans | |
Brudenell et al. | Efficient overexpression and purification of severe acute respiratory syndrome coronavirus 2 nucleocapsid proteins in Escherichia coli | |
CN110157725A (zh) | 使不产毒微藻产生微囊藻毒素的方法及得到的产毒微藻 | |
Coker et al. | FAS2FURIOUS: Moderate-Throughput Secreted Expression of Difficult Recombinant Proteins in Drosophila S2 Cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161122 Address after: 430000 Hubei Province, Wuhan city Wuchang District Luojia Hill No. 16 Patentee after: Xu Henghao Patentee after: Gao Song Address before: 222000 Sinpo District, Jiangsu, Henan Province, No. filling South Road, No. 108 Patentee before: LIANYUNGANG ZHILIFANG BIOLOGICAL MEDICAL INSTITUTE CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171017 Address after: 222000 17-1-1005, Lianyungang, Haizhou, Jiangsu Province, 1006 Patentee after: JIANGSU YUGONG BIOLABS TECHNOLOGY CO.,LTD. Address before: 430000 Hubei Province, Wuhan city Wuchang District Luojia Hill No. 16 Co-patentee before: Gao Song Patentee before: Xu Henghao |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Display of foreign protein macromolecules on the surface of T4 phage by intracellular synchronous expression method Effective date of registration: 20211013 Granted publication date: 20141029 Pledgee: Lianyungang gesda Financing Guarantee Co.,Ltd. Pledgor: JIANGSU YUGONG BIOLABS TECHNOLOGY Co.,Ltd. Registration number: Y2021980010616 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230404 Granted publication date: 20141029 Pledgee: Lianyungang gesda Financing Guarantee Co.,Ltd. Pledgor: JIANGSU YUGONG BIOLABS TECHNOLOGY CO.,LTD. Registration number: Y2021980010616 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Method for Displaying Foreign Protein Macromolecules on the Surface of T4 Phage Using Intracellular Synchronous Expression Effective date of registration: 20230427 Granted publication date: 20141029 Pledgee: Lianyungang gesda Financing Guarantee Co.,Ltd. Pledgor: JIANGSU YUGONG BIOLABS TECHNOLOGY CO.,LTD. Registration number: Y2023980039375 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231012 Granted publication date: 20141029 Pledgee: Lianyungang gesda Financing Guarantee Co.,Ltd. Pledgor: JIANGSU YUGONG BIOLABS TECHNOLOGY CO.,LTD. Registration number: Y2023980039375 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231220 Address after: 222000 floor 2, building e, International Pharmaceutical Innovation Industrial Park, No. 28, Yuehu Road, Lianyungang Economic and Technological Development Zone, China (Jiangsu) pilot Free Trade Zone, Lianyungang City, Jiangsu Province Patentee after: Jiangsu Yugong Biotechnology Co.,Ltd. Address before: 222000 17-1-1005-1006, Huaguoshan Avenue, Haizhou District, Lianyungang City, Jiangsu Province Patentee before: JIANGSU YUGONG BIOLABS TECHNOLOGY CO.,LTD. |